Cytomos Overview

  • Founded
  • 2011
  • Status
  • Private
  • Employees
  • 8
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $2.13M
Latest Deal Amount
  • Investors
  • 2

Cytomos General Information


Developer of a dielectric spectroscopy technology designed to assist in label-free cell analysis for biomedical research. The company's patented cell analysis technology ensures that every cell is analyzed providing granular information on individual cells and the whole sample population, facilitates automated and quantitative sample assessment, phenotypic drug discovery and stem cell therapy, enabling medical researchers to find functional endpoints that generate high-content fingerprints to prepare the right dose thereby making cell-based diagnostics efficient.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Laboratory Services (Healthcare)
Drug Discovery
Primary Office
  • 13 Melville Street
  • Edinburgh EH3 7PE
  • Scotland, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytomos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 23-Apr-2018 $2.13M 00.000 00.000 Completed Startup
2. Early Stage VC 16-Feb-2016 00000 00000 00.000 Completed Startup
1. Angel (individual) 15-Dec-2014 $157K $157K 00000 Completed Startup
To view Cytomos’s complete valuation and funding history, request access »

Cytomos Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 19,800 $0.000014 $7.14 $7.14 1x $7.14 4.78%
To view Cytomos’s complete cap table history, request access »

Cytomos Executive Team (1)

Name Title Board Seat Contact Info
Keith Muir Ph.D Founder, Board Member & Chief Executive Officer
To view Cytomos’s complete executive team members history, request access »

Cytomos Board Members (4)

Name Representing Role Since
Alister Minty Self Chairman 000 0000
Gino Miele Ph.D Cytomos Board Member 000 0000
Keith Muir Ph.D Cytomos Founder, Board Member & Chief Executive Officer 000 0000
Margaret Temple Self Board Member 000 0000
To view Cytomos’s complete board members history, request access »

Cytomos Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cytomos Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Scottish Enterprise Venture Capital Minority 000 0000 000000 0
Archangel Investors Angel Group Minority 000 0000 000000 0
To view Cytomos’s complete investors history, request access »